Consequently, large, long-term, and specifically designed randomized controlled trials (RCTs) are necessary to accurately evaluate GLP-1 RAs impact on hypertension and determine their potential benefits and limitations [86]
nurses stepping off the picket lines amid mediation02:07 | July 14, 2026 New tick-borne illness on the rise in Canada02:09 | July 13, 2026 Health Matters: Ontario and Manitoba to get hammered by heat wave02:05 | July 13, 2026 Health Matters: Alberta auditor general to finish health probe by end-of-year02:19 | July 9, 2026 Health Matters: Toronto Public Health reports nearly 40 heat-related E.R
These damages may cause not just photo-aging (like age spots and wrinkles) but also a significant increase in the risk of carcinogenesis in the skin and cataract formation of the eye lens
But in the beginning of last year, we, we said, no, it has to be for a diabetes prescription. -Senior Human Resources Leader, large services organization The use of GLP-1 agonists was higher than expected for many large employers including for over half (59%) of employers over 5,000 workers Since then, many larger employers covering GLP-1 agonists for weight loss reported higher than expected use of the medications and significant impacts on their prescription spending